Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer

BACKGROUND: T-cell based immunotherapy for lung cancer (LC) could be a promising and novel therapeutic approach. Six-transmembrane epithelial antigen of the prostate (STEAP) and the polycomb group protein enhancer of zeste homolog 2 (EZH2) are highly expressed in LC and since the expression of molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Satoshi, Kumai, Takumi, Matsuda, Yoshiya, Aoki, Naoko, Sato, Keisuke, Kimura, Shoji, Kitada, Masahiro, Tateno, Masatoshi, Celis, Esteban, Kobayashi, Hiroya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219573/
https://www.ncbi.nlm.nih.gov/pubmed/22053850
http://dx.doi.org/10.1186/1479-5876-9-191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219573/
https://www.ncbi.nlm.nih.gov/pubmed/22053850
http://dx.doi.org/10.1186/1479-5876-9-191

Ejemplares similares